IP Library Patent Application 10491887
Patent Application
App. No. 10/491,887

Method for improving dissolution of poorly dispersible medicaments

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
10/491,887
Abstract

The present invention is to provide a method for improving the dissolution of a poorly dispersible medicament and that is achieved by preparing a granulated product where a floating agent is added to the poorly dispersible medicament.

Claims (13)

1 - 18 . (Canceled).

19 . A granulated product where dissolution of a poorly dispersible medicament is improved, which comprises the poorly dispersible medicament and a floating agent, wherein the dissolution of the poorly dispersible medicament is improved by the floating agent.

20 . The granulated product according to claim 19 , which further comprises a surfactant.

21 . The granulated product according to claim 20 , wherein the granulated product is manufactured by an extrusion granulation.

22 . The granulated product according to claim 20 , wherein the granulated product is in a form of fine granules.

23 . A capsule which comprises the granulated product described in claim 20 .

24 . A tablet which comprises the granulated product described in claim 20 .

25 . The granulated product according to claim 20 , wherein the floating agent is non-water-soluble cellulose, sodium alginate, propylene glycol alginate, tragacanth powder or xanthan gum.

26 . The granulated product according to claim 20 , wherein the surfactant is sodium lauryl sulfate, polyoxyl 40 stearate, sucrose fatty acid ester, polyoxyethylene hydrogenated castor oil, polyoxyethylene polyoxypropylene glycol or polyoxyethylene sorbitan fatty acid ester.

27 . The granulated product according to claim 20 , wherein the poorly dispersible medicament is 11-[4-[2-(2-hydroxyethoxy)ethyl]-1-piperazinyl]-dibenzo[b,f][1,4]thiazepine or a salt thereof.

28 . The granulated product according to claim 27 , wherein the floating agent is crystalline cellulose and the surfactant is sodium lauryl sulfate.

29 . The granulated product according to claim 28 , wherein the granulated product is manufactured by an extrusion granulation.

30 . The granulated product according to claim 28 , wherein the granulated product is in a form of fine granules.

Assignments (2)
MERGER Recorded Dec 12, 2005
From: FUJISAWA PHARMACEUTICAL CO., LTD.
To: ASTELLAS PHARMA INC.
Reel/Frame 017073/0257 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 10, 2004
From: YAMAGUCHI, HISAMI; SAKA, SHUJI; UEDA, TAKAO
To: FUJISAWA PHARMACEUTICAL CO., LTD.
Reel/Frame 015310/0941 →